3Rd Gen Anti-CD19 CAR T-Cells Demonstrate Efficacy Without Neurotoxicity In B-Cell Lymphoma Phase 1 Clinical Trial menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
BioOra together with its founding partner, the Malaghan Institute of Medical Research, announced clinical results from the ENABLE phase 1 clinical trial at the 65th American Society of Hematology (ASH) Annual Meeting in San Diego.
Phase 1 CD-19 specific third generation CAR T cell study data supports use of BioOra s automated manufacture for phase 2 einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.